Ultimately, the central lesson emerging from Europe at the moment is that within hospital and insurance markets, it often takes more regulation and a more active state in order to create meaningful competition and productive incentives.
Some research has established that medications can be cut in nursing home patients with good outcomes. But in the community, where there is often no single doctor keeping track of all the patients’ medicines, it can be challenging.
